Country/Region: Austria
Published PE Recommendations

Guidelines on Health Economic Evaluations (Concensus Paper 2006)
PDF in English; PDF in German

Published PE Recommendations Source:
Additional Information:
Last Webpage Update: Tuesday, January 16, 2018

Published PE Recommendations Key Features:

Key Features:  
Title and year of the document
Guidelines on Health Economic Evaluations (Concensus Paper 2006) 
Affiliation of authors
Institute for Pharmaeconomic Research (IPF) in cooperation with an expert group 
Purpose of the document
Providing recommendations for C/E studies and ensure a minimum standard of methodology and transparency 
Standard reporting format included
No 
Disclosure
Yes 
Target audience of funding/ author's interests
Decision makers 
Perspective
Apart from the societal perspective, other perspectives (e.g. health care system, social insurance,..) are possible 
Indication
Yes 
Target population
Be clearly specify 
Subgroup analysis
Yes 
Choice of comparator
Standard therapy, most frequent therapy or most effective therapy 
Time horizon
Depends on research question 
Assumptions required
Yes 
Preferred analytical technique
CMA, CEA, CUA 
Costs to be included
Costs relevant to the chosen perspective. Report indirect costs separately. 
Source of costs
Latest unit prices, give references. 
Modeling
Yes, requires details 
Systematic review of evidences
Not stated 
Preference for effectiveness over efficacy
Both acceptable 
Preferred outcome measure
Depends on research question 
Preferred method to derive utility
Should justify the selection 
Equity issues stated
Yes 
Discounting costs
5%; SA:(3%-10%) 
Discounting outcomes
5%; SA:(3%-10%) 
Sensitivity analysis-parameters and range
All key uncertain parameters, within a defined area, or probabilistic 
Sensitivity analysis-methods
One-way, multi-way, may be probabilistic analysis 
Presenting results
Must be reproduced transparently in disaggregated and aggregated form as for publication in peer reviewed journals 
Incremental analysis
Yes 
Total costs vs effectiveness (cost/effectiveness ratio)
Yes 
Portability of results (Generalizability)
Yes; Studies must refer to the national context 
Financial impact analysis
Possible 
Mandatory or recommended or voluntary
Recommended 

Acknowledgement: Dr. Gottfried Endel, Head of HTA Department, Main Association of Austrian Social Security Institutions contributed to the key feature form.

Country Selection Page | PE Guidelines Index Page